Increased dendritic MAP2 expression in the hippocampus in schizophrenia

Schizophrenia Research

Volumn 41, Issue 2, 2000, Pages 313-323

  Cotter, David ^a   Wilson, Simon ^a   Roberts, Eleanor ^a   Kerwin, Robert ^a   Everall, Ian Paul ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Bouffon's Needle; Dendritic length; MAP2; Schizophrenia; Stereological

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN 2;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DENDRITE; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NEEDLE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; DENDRITES; FEMALE; HIPPOCAMPUS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; PYRAMIDAL CELLS; SCHIZOPHRENIA;

EID: 0033973980     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(99)00068-7     Document Type: Article

References (47)

1. Aherne W.A., Dunhill M.S. Morphometry. 1982;Edward Arnold, London.
2. Akbarian S., Vinuela A., Kimm J., Potkin S.G., Bunney W.E., Jones E.G. Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in temporal lobe of schizophrenics implies disturbances of cortical development. Arch. Gen. Psychiatry. 50:1993;178-187.
3. Akbarian S., Kimm J., Potkin S.G., Hetrick W., Bunney W.E., Jones E.G. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch. Gen. Psychiatry. 53:1993;425-436.
4. Amaral D.G., Insausti R. Hippocampal formation. Paxinos G. The Human Nervous System. 1990;711-756 Academic Press.
5. Arnold S.E., Lee V.M.Y., Gur R.E., Trojanowski J.Q. Abnormal expression of two microtubule associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia. Proc. Natl. Acad. Sci. USA. 88:1991;10850-10854.
6. Arnold S.E., Hyman B.T., Hoesen G.W.V., Damasio A.R. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch. Gen. Psychiatry. 48:1991;625-632.
7. Arnold S.E., Franz B.R., Gur R.C., Gur R.E, Shapiro R.M., Moberg P.J., Trojanowski J.Q. Smaller interneuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. Am. J. Psychiatry. 152:1995;738-748.
8. Arnold S.E., Trojanowski J.Q. Recent advances in defining the neuropathology of schizophrenia. Acta Neuropathol. 92:1996;217-231.
9. Bazire S. Psychotropic Drug Directory. 1995;Mark Allen Publishing, Wiltshire.
10. Benes F.M., Davidson J., Bird E.D. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch. Gen. Psychiatry. 43:1986;31-35.
11. Benes F.M., Bird E.D. An analysis of the arrangment of neurons in the cingulate cortex of schizophrenic patients. Arch. Gen. Psychiatry. 44:1987;608-616.
12. Benes F.M., Sorensen I., Bird E.D. Reduced neuronal size in the posterior hippocampus of schizophrenic patients. Schizophr. Bull. 17:1991;597-608.
13. Bogerts B., Meertz E., Schonfeldt-Bausch R. Basal ganglia and limbic system pathology in schizophrenia: a morphometric study of brain volume and shrinkage. Arch. Gen. Psychiatry. 42:1985;784-791.
14. Brion J.P., Guilleminot J., Couche D., Flament-Durand J., Nunez J. Both adult and juvenile tau microtubule-associated proteins are axon specific in the developing and adult rat cerebellum. Neuroscience. 25:(1):1988;139-146.
15. Browning M.D., Dudeck E.M., Rapier J.L., Leonard S., Freedman R. Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics. Biol. Psychiatry. 34:1993;528-535.
16. Cotter D., Kerwin R., Doshi R., Everall E. Alterations in hippocampal non-phosphorylated MAP2 expression in schizophrenia. Brain Res. 765:(2):1997;238-246.
17. Dwork A.J. Schizophr. Bull. 23:(3):1997;385-402.
18. Eastwood S.L., Burnet P.J., Harrison P.J. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience. 66:1995;201-206.
19. Everall I.P., DeTeresa R., Terry R., Masliah E. Comparison of two quantitative methods for the evaluation of neuronal number in the frontal cortex in Alzheimer disease. J. Neuropathol. Exp. Neurol. 56:(11):1997;1202-1206.
20. Falkai P., Bogerts B. Cell loss in the hippocampus of schizophrenics. Eur. Arch. Psychiatry Neurol. Sci. 236:1986;154-161.
21. Garey L.J., Ong W.Y., Patel T.S., Kanani M., Davis A., Hornstein C., Bauer M. Reduction in dendritic spine number on cortical pyramidal neurons in schizophrenia. Soc. Neurosci. Abs. 21:1995;237.
22. Glantz L.A., Lewis D.A. Assessment of spine density on layer III pyramidal cells in the prefrontal cortex of schizophrenic subjects. Soc. Neurosci. Abs. 21:1995;239.
23. Glantz L.A., Lewis D.A. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Arch. Gen. Psychiatry. 54:(10):1997;943-952. corrected and republished article originally appeared in Arch. Gen. Psychiatry, 54(7), 660-669.
24. Harrison P.J., Eastwood S.L. Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia. Lancet. 352:(9141):1998;1669-1673.
25. Heckers S., Heinsen Y.C., Geiger B., Beckmann H. Hippocampal neuron number in schizophrenia. A stereological study. Arch. Gen. Psychiatry. 48:1991;1002-1008.
26. Jacob H., Beckmann H. Prenatal development disturbances in the limbic allocortex in schizophrenics. J. Neural Trans. 65:1986;303-326.
27. Jeste D.V., Lohr J.B. Hippocampal pathologic findings in schizophrenia: a morphometric study. Arch. Gen. Psychiatry. 46:1989;1019-1024.
28. Johnson G.V., Jope R.S. The role of microtubule-associated protein 2 (MAP-2) in neuronal growth plasticity and degeneration. J. Neurosci. Res. 33:(4):1992;505-512.
29. Kerwin R.W. Glutamate receptors, microtubule associated proteins and developmental anomaly in schizophrenia: an hypothesis. Psychol. Med. 23:1993;547-551.
30. Krimer L.S., Herman M.M., Saunders R.C., Boyd J.C., Hyde T.M., et al. Cerebral Cortex. 7:(8):1997;732-739.
31. Lorento de No R. Studies on the structure of the cerebral cortex, II: continuation on the study of the ammonic system. J. Psychiatry Neurol. 46:1934;113-177.
32. Mirra S.S., Heyman M.D., McKeel D., Sumi M.D., Crain M.D., et al. The consortium to establish a registry for Alzheimer's Disease (CERAD). Part II. Standardisation of the neuropathological assessment of Alzheimers Disease. Neurology. 41:1991;479-486.
33. Murray R.M., O'Callaghan E., Castle D.J., Lewis S.W. A neurodevelopmental approach to the classification of schizophrenia. Schizophr. Bull. 18:(2):1992;319-322.
34. Nunez J., et al. Differential expression of microtubule components during brain development. Dev. Neurosci. 8:1986;125-141.
35. Ong W.Y., Garey L.J. Ultrastructural features of biopsied temporopolar cortex (area 38) in a case of schizophrenia. Schizophr. Res. 10:(1):1993;15-27.
36. Pakkenberg B., Gundersen H.J.G. Total number of neurons and glial cells in human brain nuclei estimated by the disector and the fractionator. J. Microsc. 150:(Pt. 1):1988;1-20.
37. Perrone-Bizzozero N., Sower A.C., Bird E.D. Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia. Proc. Natl. Acad. Sci. USA. 93:1996;14128-14187.
38. Rajkowska G., Selemon L.D., Goldman-Rakic P.S. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch. Gen. Psychiatry. 55:1998;215.
39. Roberts N., Cruz-Orive L.M. Spatial distribution of curve length: concept and estimation. J. Microsc. 172:(1):1993;23-29.
40. Roberts G.W., Colter N., Lofthouse R., Johnstone E.C., Crow T.J. Is there gliosis in schizophrenia? Investigation of the temporal lobe. Biol. Psychiatry. 22:1987;1459-1468.
41. Rosoklija M.A., Kaufman D., Liu A.P., Hays N., Latov C., Kielp A., Wu A., Sadiq J., Gorman I., Prohovnik A.J., Dwork A.J. Subicular MAP-2 immunoreactivity in schizophrenia. Soc. Neurosci. 21:1995;21216.
42. Sanchez C., Diaz-Nido J., Avila J. Variations in vivo phosphorylation at the proline-rich domain of the microtubule associated protein 2 (MAP2) changes during rat development. Biochem J. 306:(2):1995;481-487.
43. Selemon L.D., Rajakowska G., Goldman-Rakic P.S. Abnormally high neuronal density in the schizophrenic cortex A morphometric analysis of prefrontal area 9 and occipital area 17. Arch. Gen. Psychiatry. 52:1995;805-818.
44. Schwab C., Bondada V., Sparks L., Cahan L.D., Geddes J.W. Postmortem changes in the levels and localisation of microtubule associated proteins (TAU, MAP2 and MAP1B) in the rat and human hippocampus. Hippocampus. 4:(2):1994;210-225.
45. Singh N., Miller K.D., Isaacson P.G. Microwave antigen retrieval: a new experience. J. Pathol. 169:1993;21-22.
46. Weinberger D.J. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry. 44:(7):1987;660-669.
47. Zaidel D.W., Esiri M.M., Harrison P.J. Size shape and orientation of neurons in the left and right hippocampus: investigation of normal asymmetries and alterations in schizophrenia. Am. J. Psychiatry. 154:(6):1997;812-818.